KETANKUMAR GHAGHADA to Humans
This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Humans.
Connection Strength
0.216
-
Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb; 17(1):e70004.
Score: 0.025
-
Advances in nanoprobes for molecular MRI of Alzheimer's disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr; 16(2):e1946.
Score: 0.023
-
Pre-clinical dose-ranging efficacy, pharmacokinetics, tissue biodistribution, and toxicity of a targeted contrast agent for MRI of amyloid deposition in Alzheimer's disease. Sci Rep. 2020 09 30; 10(1):16185.
Score: 0.018
-
Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors. Phys Med Biol. 2019 03 12; 64(6):065007.
Score: 0.017
-
Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta. Placenta. 2017 Sep; 57:60-70.
Score: 0.015
-
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
Score: 0.014
-
Crossing the barrier: treatment of brain tumors using nanochain particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 09; 8(5):678-95.
Score: 0.013
-
Liposomal contrast agents in brain tumor imaging. Neuroimaging Clin N Am. 2010 Aug; 20(3):367-78.
Score: 0.009
-
Immature Acta2R179C/+ smooth muscle cells cause moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS. Nat Commun. 2025 Jul 02; 16(1):6105.
Score: 0.006
-
Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
Score: 0.006
-
Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models. Arterioscler Thromb Vasc Biol. 2025 May; 45(5):609-631.
Score: 0.006
-
Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum. Placenta. 2025 Feb; 160:100-106.
Score: 0.006
-
Advanced photon counting CT imaging pipeline for cardiac phenotyping of apolipoprotein E mouse models. PLoS One. 2023; 18(10):e0291733.
Score: 0.006
-
Rational Design of a Self-Assembling High Performance Organic Nanofluorophore for Intraoperative NIR-II Image-Guided Tumor Resection of Oral Cancer. Adv Sci (Weinh). 2023 04; 10(10):e2206435.
Score: 0.005
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.005
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.005
-
Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Adv Healthc Mater. 2021 03; 10(5):e2001044.
Score: 0.005
-
miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
Score: 0.005
-
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020 07; 6(28):eaba6156.
Score: 0.005
-
Effect of Dose and Selection of Two Different Ligands on the Deposition and Antitumor Efficacy of Targeted Nanoparticles in Brain Tumors. Mol Pharm. 2019 10 07; 16(10):4352-4360.
Score: 0.004
-
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
Score: 0.004
-
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev. 2014 Sep 30; 76:79-97.
Score: 0.003
-
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond). 2014 Jan; 9(1):121-34.
Score: 0.003
-
Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release. 2014 Jan 10; 173:51-8.
Score: 0.003
-
High-resolution CT vascular imaging using blood pool contrast agents. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):18-22.
Score: 0.003
-
Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget. 2011 Apr; 2(4):298-304.
Score: 0.002